[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100188509":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":18,"centralContacts":23,"locations":29,"responsibleParty":48,"collaborators":50,"id":54,"slug":55,"hasResults":56,"nctId":57,"briefTitle":58,"officialTitle":59,"acronym":18,"eligibilityCriteria":60,"healthyVolunteers":56,"sex":61,"minAge":62,"maxAge":63,"enrollmentInfo":64,"targetDuration":18,"studyType":67,"phases":68,"briefSummary":70,"conditions":71,"keywords":74,"overallStatus":53,"whyStopped":18,"lastUpdateSubmitDate":80,"lastUpdatePostDateStruct":81,"startDateStruct":83,"completionDateStruct":85,"leadSponsor":87,"locationsCount":88},{"fullName":5,"class":6},"Shalvata Mental Health Center","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Experimental: Tele-medicine monitoring","EXPERIMENTAL","Tele-medicine monitoring of medication adherence will be given to the study group as an add-on to routine out-patient treatment",[13],"Other: Tele-medicine monitoring of medication adherence",{"label":15,"type":16,"description":17,"interventionNames":18},"No Intervention: Control Rutine out-patient treatment","NO_INTERVENTION","routine out-patient treatment will be given to the control group",null,[20],{"type":6,"name":21,"description":18,"armGroupLabels":22,"otherNames":18},"Tele-medicine monitoring of medication adherence",[9],[24],{"name":25,"role":26,"phone":27,"phoneExt":18,"email":28},"Israel Krieger, Dr. Med","CONTACT","+97297478665","israelkr@clalit.org.il",[30],{"facility":31,"status":32,"city":33,"state":18,"zip":34,"country":35,"countryCode":36,"cosmosGeoPoint":37,"geoPoint":42,"contacts":43},"Shalvata MHC","RECRUITING","Hod HaSharon","45100","Israel","IL",{"type":38,"coordinates":39},"Point",[40,41],34.8932,32.15934,{"lat":41,"lon":40},[44,46],{"name":45,"role":26,"phone":27,"phoneExt":18,"email":28},"Israel Krieger, Dr' Med",{"name":45,"role":47,"phone":18,"phoneExt":18,"email":18},"PRINCIPAL_INVESTIGATOR",{"type":49,"investigatorFullName":18,"investigatorTitle":18,"investigatorAffiliation":18,"oldNameTitle":18,"oldOrganization":18},"SPONSOR",[51],{"name":52,"class":53},"SHL Telemedicine Ltd.","UNKNOWN","100188509","measuring-the-effect-of-remote-monitoring-of-treatment-adherence-on-the-risk-of-re-admission-of-ambulatory-schizophrenic-patients-100188509",false,"NCT01729572","Measuring the Effect of Remote Monitoring of Treatment Adherence on the Risk of Re-admission of Ambulatory Schizophrenic Patients","The Effect of add-on Tele Medicine Monitoring of Medication Adherence, on the Risk of Re-hospitalisation of Ambulatory Schizophrenic Patients. an Open, Prospective, Randomised Controled Trial","Inclusion Criteria:\n\n* DSM 4 diagnosis of schizophrenia or schizoaffective\n* able to give written informed consent\n* Have a telephone line\n\nExclusion Criteria:\n\n* Are not discharged to a place with routine medication monitoring\n* Are not discharged under forced ambulatory treatment order\n* Are not homeless\n* Are not admitted due to drug intoxication or withdrawal.\n* Are not admitted due to severe self harm.","ALL","18 Years","70 Years",{"count":65,"type":66},200,"ESTIMATED","INTERVENTIONAL",[69],"NA","Schizophrenia is a chronic debilitating mental disorder, characterised by a relapsing remitting course. Although anti-psychotics can prevent relapse, its effect on schizophrenia outcome remains very limited, mainly due to very poor adherence to medications by the patients. This study aims to find, whether the add-on of remote monitoring of medication compliance via tele-medicine, to routine out-patient clinic care, can improve patients adherence and reduce the risk of relapse.",[72,73],"Schizophrenia","Schizoaffective Disorder",[75,73,76,77,78,79],"schizophrenia","disease management","treatment","rehabilitation","pharmacotherapy","2014-04-24",{"date":82,"type":66},"2014-04-25",{"date":84,"type":18},"2014-01",{"date":86,"type":66},"2015-08",{"name":5,"class":6},1]